Recent BioUtah News & Events

Data shared in oral presentation at American Diabetes Association 82nd Scientific Sessions® and published in Kidney360 highlights importance in early understanding of cardiovascular risk, a leading cause of death in patients with diabetes and chronic kidney disease

PolarityTE announced that it has entered into securities purchase agreements with a single healthcare-focused institutional investor

Profil has conducted over 30 biosimilar insulin trials and is the leading clinical research organization for studies related to diabetes.

BIOMERICS ANNOUNCES EXPANSION INTO IRELAND Expanding High-Performance Balloon Design & Development Capabilities in Galway

Co-Diagnostics announced that it has completed the principal design work of a PCR test for the monkeypox virus currently exhibiting a multi-country outbreak.

BioUtah has established a partnership with Invest Lithuania, an arm of the Lithuanian government focused on developing life sciences in their country. The life sciences sector in Lithuania is regarded as one of the most highly developed in Central and Eastern Europe (CEE). The sector is driven by innovation and aims to become Europe’s next […]

SALT LAKE CITY, UTAH (Monday, May 2, 2022) – Biomerics, a leading vertically integrated contract manufacturer for the attractive interventional device market, announced the creation of a new division, Biomerics Image Guided Intervention (IGI). Biomerics’ IGI Division, headquartered in Salt Lake City, provides advanced image generation and processing technologies to enable real-time minimally invasive advanced […]

Marcy l’Étoile, France – bioMérieux, a world leader in the field of in vitro diagnostics, today announces that its BIOFIRE® Joint Infection (JI) Panel has received De Novo authorization from the US Food and Drug Administration (FDA). This panel tests for 31 pathogens implicated in most acute joint infections, and also includes 8 antimicrobial resistance (AMR) […]

PolarityTE announced that the Company will effectuate a 1-for-25 reverse stock split of the Company’s issued and outstanding common stock.

PolarityTE provided a business update and reported financial results for the three-month period ended March 31, 2022.

PolarityTE announced that the U.S. FDA granted a Regenerative Medicine Advanced Therapy (RMAT) designation to SkinTE under the Company’s open IND. 

The BioHive community was featured prominently at the One Utah Summit held on May 10 at the Grand America Hotel in Salt Lake City. Speakers from the life sciences industry addressed the crowd on topics ranging from job creation and talent development to life-saving innovation and drug discovery. Tom Polen, CEO of BD, and Rob […]

Recursion Co-founder and CEO, Chris Gibson, Ph.D., was honored at the One Utah Summit on May 10, receiving the Governor’s Medal for Science and Technology. Gov. Spencer Cox presented the award during the summit’s special recognition ceremony. The prestigious award commends the distinguished service, significant achievement, and positive economic impact of individuals to the state […]

Recursion CEO, Chris Gibson, Ph.D., was honored at the One Utah Summit on May 10, receiving the Governor’s Medal for Science and Technology. Gov. Spencer Cox presented the award which recognizes the distinguished service, significant achievement, and positive economic impact of individuals to the state of Utah and beyond in the fields of science and […]

IONIQ Receives Three Awards including ‘Best Medical Technology Company 2022’

RENOVA iStim™ implantable tibial neuromodulation device is being studied as a minimally invasive, patient-centric solution for the treatment of OAB.

New Executive Appointments Position ARUP Laboratories for Future Growth

Foldax announced that the first patients have been enrolled in the Drugs Controller General of India (DCGI)-approved clinical trial of the TRIATM biopolymer surgical aortic heart valve.

Bipartisan Agreement Will Support Innovation, Lower Costs, and Improve People’s Lives Washington, D.C. – Energy and Commerce Committee Chairman Frank Pallone, Jr. (D-NJ), Ranking Member Cathy McMorris Rodgers (R-WA), Health Subcommittee Chairwoman Anna G. Eshoo (D-CA), and Health Subcommittee Ranking Member Brett Guthrie (R-KY) today unveiled a comprehensive legislative package to reauthorize the Food and Drug […]

SALT LAKE CITY, UTAH (Monday, May 2, 2022) – Biomerics, a leading vertically integrated contract manufacturer for the attractive interventional device market, announced the creation of a new division, Biomerics Image Guided Intervention (IGI). Biomerics’ IGI Division, headquartered in Salt Lake City, provides advanced image generation and processing technologies to enable real-time minimally invasive advanced […]

Genovac announces that the company has acquired Carterra’s LSA platform for use in its discovery services. Genovac, previously a part of Aldevron before a management buyout in 2020, has been providing discovery services to life science researchers since 1999 from its site in Freiburg, Germany. More recently, Genovac added production, characterization, and cell line development […]

Expected to launch in May 2022, the novel system addresses traumatic tendon lacerations in the hand, wrist, and forearm CoNextions Inc., an innovator in tendon repair, is pleased to announce that CoNextions TR Tendon Repair System has received FDA 510(k) Clearance. Expected to launch in May 2022, the novel system addresses traumatic tendon lacerations in […]

The Phantom X system uses muscle-sensing implant technology to enable greater mobility in people with orthopedic injuries. SALT LAKE CITY and AUSTIN, Texas, April 26, 2022 /PRNewswire/ — Blackrock Neurotech, an  industry leader in brain-computer interface (BCI) technology, and Phantom Neuro, a recently launched neurotech startup that delivers a high accuracy system for lifelike control of robotic […]

Highlights: Revenue of $164.9 million for the quarter ended March 31, 2022 Excluding revenue from divested businesses, revenue increased 11% year-over-year Diluted GAAP earnings per share (EPS) of $(0.26) and adjusted EPS of $(0.03) in the first quarter of 2022 improved by $0.26 and $0.03 year-over-year, respectively Ended the quarter with $339.2 million in cash, […]